Human Stem Cells Overexpressing miR-21 Promote Angiogenesis in Critical Limb Ischemia by Targeting CHIP to Enhance HIF-1α Activity
Authors:
Open Access
- 24 February 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 34 (4) , 924-934
Abstract
Critical limb ischemia (CLI) is a severe blockage in the arteries of the lower extremities. However, the effective and optimal treatment for CLI remains to be elucidated. Previous therapeutic research is mainly focused on proangiogenic growth factors administrations. Recently, miR-21 has been revealed to play a crucial role in angiogenesis. Thus, we hypothesize that miR-21 over-expression in human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs) can effectively treat CLI. Herein, UCBMSCs were transduced with lentivirus-miR-21-Luciferase (Lenti-miR-21) or lentivirus- LacZ-Luciferase (Lenti-LacZ). The results indicated that miR-21 induced UCBMSCs proliferation, migration, and angiogenesis in vitro. Subsequently, general observation and laser Doppler perfusion imaging were introduced to detect perfusion in muscles of CLI-nude mice on 1, 4, 7, 14, and 28 day postoperation. There was a significant improvement in blood vessels of the ischemic limb in Lenti-miR-21 group at 7 day compared with the saline or Lenti-LacZ groups. At 28 day, histological analysis confirmed that UCBMSCs over-expressing miR-21 increased neovascularization in CLI. Furthermore, carboxyl terminus of Hsc70-interacting protein (CHIP) was found to be the target gene for miR-21-mediated activation of hypoxia-inducible factor 1α (HIF-1α) in UCBMSCs. In summary, our study demonstrated that over-expressing miR-21 in UCBMSCs could improve neovascularization in CLI through enhancing HIF-1α activity by targeting CHIP, which may hold great therapeutic promise in treating CLI.Keywords
Funding Information
- National Natural Science Foundation of China (31370983, 81371190, 81401518, 31501103)
- ITI Grant (930_2013)
- Anhui Province Funds for Distinguished Young Scientists (1508085J08)
- Young Top-Notch Talent Support Scheme from Anhui Medical University and Anhui Provincial Natural Science Foundation (1408085QH180, 1508085QC62)
This publication has 56 references indexed in Scilit:
- Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?Molecular Interventions, 2010
- Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic miceProceedings of the National Academy of Sciences, 2009
- Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord bloodBritish Journal of Haematology, 2009
- miR-21 as a key regulator of oncogenic processesBiochemical Society Transactions, 2009
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cellsNucleic Acids Research, 2009
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase RegulatorsMolecular and Cellular Biology, 2008
- CHIP Deficiency Decreases Longevity, with Accelerated Aging Phenotypes Accompanied by Altered Protein Quality ControlMolecular and Cellular Biology, 2008
- MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular CancerGastroenterology, 2007
- A MicroRNA Signature of HypoxiaMolecular and Cellular Biology, 2007
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003